However, circulating levels of FGF21 are elevated in obesity and insulin-resistant states, therefore it is not clear if attempts to (in)directly increase levels further will be of therapeutic benefit in humans8, 11, 14. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.